Dr. Piers Nash is a dynamic leader at the forefront of innovation in the life sciences and healthcare sectors, serving as the Founder and CEO of Sympatic Inc. With a robust academic foundation, including a Ph.D. in Biochemistry from the University of Alberta and an...
Dr. Piers Nash is a dynamic leader at the forefront of innovation in the life sciences and healthcare sectors, serving as the Founder and CEO of Sympatic Inc. With a robust academic foundation, including a Ph.D. in Biochemistry from the University of Alberta and an MBA with high honors from the Chicago Booth School of Business, Piers combines scientific rigor with business acumen to drive transformative change. Under his leadership, Sympatic has developed a groundbreaking data collaboration platform that leverages API-driven third-party trust cloud orchestration and run-time management, revolutionizing ethical data sharing practices across the industry.
Piers is particularly passionate about harnessing the power of cloud storage and software-defined networking to enhance data security and accessibility in healthcare. His innovative approach has led to the creation of the Sympatic VirtualVault, a key technology that ensures sensitive data is managed with the utmost integrity and compliance. This platform not only facilitates seamless collaboration among researchers and healthcare providers but also accelerates drug development processes by enabling real-time data analysis and sharing.
In addition to his technical expertise, Piers is an accomplished educator, skilled in university teaching and presentations, which he utilizes to foster a culture of continuous learning within his team. His extensive background in enzymology and biotechnology positions him as a thought leader in the industry, allowing him to effectively bridge the gap between scientific research and practical application. As he continues to push the boundaries of what's possible in data collaboration, Dr. Piers Nash remains committed to advancing the future of healthcare through innovation and ethical practices.
